Literature DB >> 9096140

Heterogeneous topographic and cellular distribution of huntingtin expression in the normal human neostriatum.

R J Ferrante1, C A Gutekunst, F Persichetti, S M McNeil, N W Kowall, J F Gusella, M E MacDonald, M F Beal, S M Hersch.   

Abstract

A striking heterogeneous distribution of topographic and cellular huntingtin immunoreactivity was observed within the human neostriatum using three distinct huntingtin antibodies. Patchy areas of low huntingtin immunoreactivity were present in both the caudate nucleus and putamen, surrounded by an intervening area of greater immunoreactivity. Comparison of huntingtin immunoreactivity with contiguous serial sections stained for enkephalin and calbindin D28k immunoreactivities showed that the topographic heterogeneity of huntingtin immunostaining corresponded to the patch (striosome) and matrix compartments within the striatum. Huntingtin immunoreactivity was confined primarily to neurons and neuropil within the matrix compartment, whereas little or no neuronal or neuropil huntingtin immunostaining was observed within the patch compartment. There was marked variability in the intensity of huntingtin immunolabel among medium-sized striatal neurons, whereas a majority of large striatal neurons were only faintly positive or without any immunoreactivity. Combined techniques for NADPH-diaphorase enzyme histochemistry and huntingtin immunocytochemistry, as well as double immunofluorescence for either nitric oxide synthase or calbindin D28k in comparison with huntingtin expression, revealed a striking correspondence between calbindin D28k and huntingtin immunoreactivities, with little or no colocalization between NADPH-diaphorase or nitric oxide synthase neurons and huntingtin expression. These observations suggest that the selective vulnerability of spiny striatal neurons and the matrix compartment observed in Huntington's disease is associated with higher levels of huntingtin expression, whereas the relative resistance of large and medium-sized aspiny neurons and the patch compartments to degeneration is associated with low levels of huntingtin expression.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9096140      PMCID: PMC6573626     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  49 in total

1.  Neuronal NADPH diaphorase is a nitric oxide synthase.

Authors:  B T Hope; G J Michael; K M Knigge; S R Vincent
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

2.  Selective sparing of a class of striatal neurons in Huntington's disease.

Authors:  R J Ferrante; N W Kowall; M F Beal; E P Richardson; E D Bird; J B Martin
Journal:  Science       Date:  1985-11-01       Impact factor: 47.728

Review 3.  Huntington's disease, energy, and excitotoxicity.

Authors:  M F Beal
Journal:  Neurobiol Aging       Date:  1994 Mar-Apr       Impact factor: 4.673

Review 4.  Aging, energy, and oxidative stress in neurodegenerative diseases.

Authors:  M F Beal
Journal:  Ann Neurol       Date:  1995-09       Impact factor: 10.422

5.  The distribution of GABAA-benzodiazepine receptors in the basal ganglia in Huntington's disease and in the quinolinic acid-lesioned rat.

Authors:  R L Faull; H J Waldvogel; L F Nicholson; B J Synek
Journal:  Prog Brain Res       Date:  1993       Impact factor: 2.453

6.  Expression of normal and mutant huntingtin in the developing brain.

Authors:  P G Bhide; M Day; E Sapp; C Schwarz; A Sheth; J Kim; A B Young; J Penney; J Golden; N Aronin; M DiFiglia
Journal:  J Neurosci       Date:  1996-09-01       Impact factor: 6.167

7.  Survival of basal ganglia neuropeptide Y-somatostatin neurones in Huntington's disease.

Authors:  D Dawbarn; M E De Quidt; P C Emson
Journal:  Brain Res       Date:  1985-08-12       Impact factor: 3.252

8.  The neostriatal mosaic: compartmental distribution of calcium-binding protein and parvalbumin in the basal ganglia of the rat and monkey.

Authors:  C R Gerfen; K G Baimbridge; J J Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

Review 9.  Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?

Authors:  M F Beal
Journal:  Ann Neurol       Date:  1992-02       Impact factor: 10.422

10.  Differential loss of striatal projection neurons in Huntington disease.

Authors:  A Reiner; R L Albin; K D Anderson; C J D'Amato; J B Penney; A B Young
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

View more
  36 in total

Review 1.  Polyglutamine pathogenesis.

Authors:  C A Ross; J D Wood; G Schilling; M F Peters; F C Nucifora; J K Cooper; A H Sharp; R L Margolis; D R Borchelt
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-06-29       Impact factor: 6.237

2.  Transgenic mice expressing mutated full-length HD cDNA: a paradigm for locomotor changes and selective neuronal loss in Huntington's disease.

Authors:  P H Reddy; V Charles; M Williams; G Miller; W O Whetsell; D A Tagle
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-06-29       Impact factor: 6.237

3.  Nuclear and neuropil aggregates in Huntington's disease: relationship to neuropathology.

Authors:  C A Gutekunst; S H Li; H Yi; J S Mulroy; S Kuemmerle; R Jones; D Rye; R J Ferrante; S M Hersch; X J Li
Journal:  J Neurosci       Date:  1999-04-01       Impact factor: 6.167

4.  Therapeutic effects of cystamine in a murine model of Huntington's disease.

Authors:  Alpaslan Dedeoglu; James K Kubilus; Thomas M Jeitner; Samantha A Matson; Misha Bogdanov; Neil W Kowall; Wayne R Matson; Arthur J L Cooper; Rajiv R Ratan; M Flint Beal; Steven M Hersch; Robert J Ferrante
Journal:  J Neurosci       Date:  2002-10-15       Impact factor: 6.167

5.  An upstream open reading frame impedes translation of the huntingtin gene.

Authors:  Joseph Lee; Eun Hee Park; Graeme Couture; Isabelle Harvey; Philippe Garneau; Jerry Pelletier
Journal:  Nucleic Acids Res       Date:  2002-12-01       Impact factor: 16.971

Review 6.  Huntingtin in health and disease.

Authors:  Anne B Young
Journal:  J Clin Invest       Date:  2003-02       Impact factor: 14.808

7.  Increased irritability, anxiety, and immune reactivity in transgenic Huntington's disease monkeys.

Authors:  Jessica Raper; Steven Bosinger; Zachary Johnson; Gregory Tharp; Sean P Moran; Anthony W S Chan
Journal:  Brain Behav Immun       Date:  2016-07-07       Impact factor: 7.217

8.  Mutant Huntingtin promotes autonomous microglia activation via myeloid lineage-determining factors.

Authors:  Andrea Crotti; Christopher Benner; Bilal E Kerman; David Gosselin; Clotilde Lagier-Tourenne; Chiara Zuccato; Elena Cattaneo; Fred H Gage; Don W Cleveland; Christopher K Glass
Journal:  Nat Neurosci       Date:  2014-03-02       Impact factor: 24.884

Review 9.  The ubiquitin-proteasome pathway in Huntington's disease.

Authors:  Steven Finkbeiner; Siddhartha Mitra
Journal:  ScientificWorldJournal       Date:  2008-04-20

10.  Dopamine modulates the susceptibility of striatal neurons to 3-nitropropionic acid in the rat model of Huntington's disease.

Authors:  D S Reynolds; R J Carter; A J Morton
Journal:  J Neurosci       Date:  1998-12-01       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.